162 related articles for article (PubMed ID: 10448114)
1. Progression as exemplified by human astrocytic tumors.
Collins VP
Semin Cancer Biol; 1999 Aug; 9(4):267-76. PubMed ID: 10448114
[TBL] [Abstract][Full Text] [Related]
2. Gliomas.
Collins VP
Cancer Surv; 1998; 32():37-51. PubMed ID: 10489622
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
[TBL] [Abstract][Full Text] [Related]
4. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
[TBL] [Abstract][Full Text] [Related]
5. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
Ren ZP; Olofsson T; Qu M; Hesselager G; Soussi T; Kalimo H; Smits A; Nistér M
J Neuropathol Exp Neurol; 2007 Oct; 66(10):944-54. PubMed ID: 17917588
[TBL] [Abstract][Full Text] [Related]
7. Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant.
Klein MA; Rüedi D; Nozaki M; Dell EW; Diserens AC; Seelentag W; Janzer RC; Aguzzi A; Hegi ME
Oncogene; 2000 Nov; 19(47):5329-37. PubMed ID: 11103934
[TBL] [Abstract][Full Text] [Related]
8. Clonal expansion of p53 mutant cells is associated with brain tumour progression.
Sidransky D; Mikkelsen T; Schwechheimer K; Rosenblum ML; Cavanee W; Vogelstein B
Nature; 1992 Feb; 355(6363):846-7. PubMed ID: 1311419
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 17 allelic loss in astrocytic tumors and its clinico-pathologic implications.
Muhammad AK; Yoshimine T; Maruno M; Tokiyoshi K; Takemoto O; Ninomiya H; Hayakawa T
Clin Neuropathol; 1997; 16(4):220-6. PubMed ID: 9266149
[TBL] [Abstract][Full Text] [Related]
10. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the IDH1 codon 132 mutation in brain tumors.
Balss J; Meyer J; Mueller W; Korshunov A; Hartmann C; von Deimling A
Acta Neuropathol; 2008 Dec; 116(6):597-602. PubMed ID: 18985363
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.
Ichimura K; Bolin MB; Goike HM; Schmidt EE; Moshref A; Collins VP
Cancer Res; 2000 Jan; 60(2):417-24. PubMed ID: 10667596
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of pediatric astrocytic tumors.
Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
[TBL] [Abstract][Full Text] [Related]
14. [Molecular pathology of brain tumors].
Sanz Esponera J
An R Acad Nac Med (Madr); 2005; 122(1):191-6. PubMed ID: 16173698
[TBL] [Abstract][Full Text] [Related]
15. Nucleolar organizer regions (AgNORs) in astrocytic tumors.
Pedal WP; Warzok RW; Hufnagl P; Roth K
Zentralbl Pathol; 1994 Mar; 140(1):89-94. PubMed ID: 7515679
[TBL] [Abstract][Full Text] [Related]
16. Ethnicity delineates different genetic pathways in malignant glioma.
Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M
Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
[TBL] [Abstract][Full Text] [Related]
18. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
[TBL] [Abstract][Full Text] [Related]
19. Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours.
Miyakawa A; Ichimura K; Schmidt EE; Varmeh-Ziaie S; Collins VP
Br J Cancer; 2000 Feb; 82(3):543-9. PubMed ID: 10682663
[TBL] [Abstract][Full Text] [Related]
20. Expression of the p53 protein in a spectrum of astrocytic tumours.
Ellison DW; Gatter KC; Steart PV; Lane DP; Weller RO
J Pathol; 1992 Dec; 168(4):383-6. PubMed ID: 1336544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]